Key result
Quinapril administration in hemodynamically stable rats with reduced renal mass maintained serum potassium levels without causing severe hyperkalemia, even during high potassium intake.
Why the study?
Does quinapril cause severe hyperkalemia in hemodynamically stable subjects with reduced renal mass and renal dysfunction?
Does quinapril cause severe hyperkalemia in hemodynamically stable subjects with reduced renal mass and renal dysfunction?
This preclinical study suggests that ACE inhibition does not inherently cause severe hyperkalemia in stable renal dysfunction, challenging widespread clinical assumptions.
Authors
No takes yet. Share an insight, caveat, or question.
May alleviate hyperkalemia concerns with ACE inhibition in stable reduced-renal-mass models; leaves open human translation.
García et al. (2001) studied Renal failure and azotemia (n=236). Quinapril was evaluated on Serum potassium levels and potassium balance. Quinapril administration in hemodynamically stable rats with reduced renal mass maintained serum potassium levels without causing severe hyperkalemia, even during high potassium intake.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: